Clément Bertholet
Managing Partner
Works at AdBio partners (ex Advent France Biotechnology)
Investor profile | Builders Republic
About
Managing Partner at AdBio partners (formerly Advent France Biotechnology) in Paris, Clément Bertholet invests in Seed and Series A with check sizes ranging from €1 to €3 million, focusing on a specialized thesis in biotech and life sciences. His profile combines elite scientific training and operational experience in the sector: a graduate of École Normale Supérieure and the Corps des Mines, he co-founded and led Calida Therapeutics in 2022-2023, after serving as VP of Corporate Development at Thabor Therapeutics. His background also includes research positions at Institut Curie and Cancer Research UK, solidifying his technical expertise in cellular biology and molecular epigenetics.
Profile
- Role
- Managing Partner
- Fund
- AdBio partners (ex Advent France Biotechnology)
- Nationality
- French